PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24296945-4	2014	Results confirmed that SMZL is an entity distinct from other low-grade B-cell lymphomas, and identified mutations in multiple genes involved in marginal zone development, and others involved in NF-kappaB, BCR, chromatin remodelling and the cytoskeleton.	smzl	23-27	BCR activator of RhoGEF and GTPase	Homo sapiens	205-208